Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodelingLuqi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hiroki Yokota(Indiana University Health)International Journal of OncologyJuly 13, 201810.3892/ijo.2018.4481Cited by 20SaveCiteExport RISWatch citationsRelated PapersSuppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling|Theranostics|2021|67